Login

We are 40! Talks at DFI - Steven Tsai, President of DFI Inc | Steven Tsai, CEO, DFI Inc2397:TAI 00:10:00

Share On Facebook Share On Twitter

Currently, Steven Tsai is the President of DFI Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Untangling Reality from Rhetoric: Regina Ip on Hong Kong's Future"
00:10:00
Azuma Resources: Advancing the Wa Gold Project Towards Development
00:10:00
The Last Honest Man: Frank Church's Legacy in Defending Democracy|James Risen, Professor,University of Maryland's Philip Merrill College of Journalism
00:10:00
Talks about how to deal with a remote work environment, cyber security and ESG|CEO , Blackbaud Inc
00:10:00
Dariusz Blocher, President of Budimex SA, discusses acquisition plans in the real estate market alongside insights from a Steve Jobs interview.|Artur Popko President of the Management Board, General Manager of Budimex SA
00:10:00
Walkabout Resources CEO on Robust DFS and Tanzania Graphite Project Advancements.
00:10:00
Sean of Davis Wealth Management: Avoiding Financial Pitfalls in Retirement
00:00:00
Faron Pharmaceuticals CEO delighted with latest BEXMAB study findings - Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:10:00
EFG-Hermes CEO Karim Awad on Market Trends and Investment Strategies | Karim Awad , CEO, Egypt EFG Hermes.
00:10:00
Alaska Airlines CEO Ben Minicucci Addresses Pilot Shortage Behind Sea-Tac Flight Cancellations | Ben Minicucci, CEO, Alaska Airlines.
00:10:00
Impact of TCJA Sunset on Gifting Strategies: Insights from Mark Struthers at IWI Conference | Mark Struthers - CFA founder of Sona Wealth
00:10:00
disrupt existing markets or create entirely new ones|Matt Harris,Partner,Bain Capital Ventures

© 2017 - Neuhu+